Ocular iontophoresis of EGP-437 (dexamethasone phosphate) in dry eye patients: results of a randomized clinical trial.

Patane, Michael A; Cohen, Amy; From, Stephen; Torkildsen, Gail; Welch, Donna; Ousler, George W

Patane, Michael A; Cohen, Amy; From, Stephen; Torkildsen, Gail; Welch, Donna; Ousler, George W.

Patane MA; Eyegate Pharmaceuticals, Inc, 100 Beaver Street, Waltham, MA 02453, USA. mpatane@eyegatepharma.com

Clin Ophthalmol ; 5: 633-43, 2011.

Article en En | MEDLINE | ID: mdl-21629568

Palabras clave

Controlled Adverse Environment (CAE); dry eye; iontophoresis; ocular protection index (OPI)

Texto completo

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3104791
https://dx.doi.org/10.2147/OPTH.S19349

Imprimir

XML

PubMed Links

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Clinical_trials / Prognostic_studies Idioma: En Año: 2011 Tipo del documento: Article

Texto completo

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3104791
https://dx.doi.org/10.2147/OPTH.S19349

Imprimir

XML

PubMed Links

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Clinical_trials / Prognostic_studies Idioma: En Año: 2011 Tipo del documento: Article